Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylene Blue MMX for adenoma/carcinoma detection during screening or surveillance colonoscopy
2012-003983-32Phase 3Completed
- Sponsor
- Cosmo Pharmaceuticals
- Start
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of lumeblue (3 arms), sponsored by Cosmo Pharmaceuticals. Started Aug 2013; status: completed.
02
Drugs
lumeblue
Beyond the preview
Go deeper on 2012-003983-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003983-32.